FMO5 and Insulin resistance: Hence, cerebrovascular recovery likely resulted, at least in part, from the ability of SSR240612 to antagonize the B1R-mediated production of vascular NADPH oxidase-derived reactive oxygen species [10] and inflammatory cytokines [77], as recently documented in aorta from a rat model of insulin resistance.